Company profile for Sana Biotechnology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building differentiated capabilities across the spectrum of cell and gene therapy. Three aspirations drive Sana as we look to discover treatments for patients with poor outcomes or curre...
Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building differentiated capabilities across the spectrum of cell and gene therapy. Three aspirations drive Sana as we look to discover treatments for patients with poor outcomes or currently untreatable diseases. The first is the ability to repair and control the genes in any cell in the body. We are advancing novel delivery technologies with the goal of being able to deliver any payload.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
188 E Blaine St Suite 400 Seattle, Washington 98102
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/24/3193924/0/en/Sana-Biotechnology-to-Present-at-December-2025-Investor-Conferences.html

GLOBENEWSWIRE
24 Nov 2025

https://www.fiercebiotech.com/biotech/sana-camp4-ditch-clinical-stage-assets-more-promising-preclinical-candidates

FIERCE BIOTECH
07 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3183136/0/en/Sana-Biotechnology-Reports-Third-Quarter-2025-Financial-Results-and-Business-Updates.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180858/0/en/Sana-Biotechnology-to-Present-at-the-TD-Cowen-Immunology-Inflammation-Summit.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/08/26/3139603/0/en/Sana-Biotechnology-to-Present-at-September-2025-Investor-Conferences.html

GLOBENEWSWIRE
26 Aug 2025

https://www.globenewswire.com/news-release/2025/08/20/3136716/0/en/Sana-Biotechnology-Announces-Closing-of-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html

GLOBENEWSWIRE
20 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty